The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease

Journal of Cellular Biochemistry

Volumn 116, Issue 7, 2015, Pages 1171-1178

  Kim, Tae Nyun ^a,b   Choi, Kyung Mook ^a  

^a Korea University   (South Korea)

^b Inje University   (South Korea)

Author keywords

CARDIOMETABOLIC DISEASE; SARCOPENIA; SARCOPENIC OBESITY; VISCERAL OBESITY

Indexed keywords

CYTOKINE;

AGING; ARTICLE; ATHEROSCLEROSIS; BODY COMPOSITION; BODY FAT; CALORIC INTAKE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYNAPENIA; DYSLIPIDEMIA; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MORTALITY; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SARCOPENIA; SARCOPENIC OBESITY; SUBCUTANEOUS FAT; ADIPOSE TISSUE; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM; OBESITY; PATHOLOGY;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; SARCOPENIA;

EID: 84929093799     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25077     Document Type: Article

References (54)

1. Abbatecola AM, Chiodini P, Gallo C, Lakatta E, Sutton-Tyrrell K, Tylavsky FA, Goodpaster B, de Rekeneire N, Schwartz AV, Paolisso G, Harris T,. 2012. Pulse wave velocity is associated with muscle mass decline: Health ABC study. Age (Dordr) 34: 469-478.
2. Asakura A, Komaki M, Rudnicki M,. 2001. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68: 245-253.
3. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG,. 2014. Sarcopenic obesity and risk of cardiovascular disease and mortality: A population-based cohort study of older men. J Am Geriatr Soc 62: 253-260.
4. Aubertin-Leheudre M, Lord C, Goulet ED, Khalil A, Dionne IJ,. 2006. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring) 14: 2277-2283.
5. Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ,. 2014. Sarcopenia, sarcopenic obesity and mortality in older adults: Results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 68: 1001-1007.
6. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE,. 2004. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 12: 1995-2004.
7. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM,. 2012. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481: 463-468.
8. Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS,. 2013. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 62: 921-925.
9. Buford TW, Anton SD, Judge AR, Marzetti E, Wohlgemuth SE, Carter CS, Leeuwenburgh C, Pahor M, Manini TM,. 2010. Models of accelerated sarcopenia: Critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev 9: 369-383.
10. Church TS, Earnest CP, Skinner JS, Blair SN,. 2007. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: A randomized controlled trial. JAMA 297: 2081-2091.
11. Clark BC, Manini TM,. 2010. Functional consequences of sarcopenia and dynapenia in the elderly. Curr Opin Clin Nutr Metab Care 13: 271-276.
12. Clark BC, Manini TM,. 2012. What is dynapenia Nutrition 28: 495-503.
13. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M,. 2010. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39: 412-423.
14. Davidson LE, Hudson R, Kilpatrick K, Kuk JL, McMillan K, Janiszewski PM, Lee S, Lam M, Ross R,. 2009. Effects of exercise modality on insulin resistance and functional limitation in older adults: A randomized controlled trial. Arch Intern Med 169: 122-131.
15. Despres JP, Lemieux I,. 2006. Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
16. Dominguez LJ, Barbagallo M,. 2007. The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr 2: 183-189.
17. Han SS, Kim KW, Kim KI, Na KY, Chae DW, Kim S, Chin HJ,. 2010. Lean mass index: A better predictor of mortality than body mass index in elderly Asians. J Am Geriatr Soc 58: 312-317.
18. Heitmann BL, Frederiksen P,. 2009. Thigh circumference and risk of heart disease and premature death: Prospective cohort study. BMJ 339: b3292.
19. Honda H, Qureshi AR, Axelsson J, Heimburger O, Suliman ME, Barany P, Stenvinkel P, Lindholm B,. 2007. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 86: 633-638.
20. Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM,. 2014. Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study. Hepatology 59: 1772-1778.
21. Janssen I,. 2010. Evolution of sarcopenia research. Appl Physiol Nutr Metab 35: 707-712.
22. Jurca R, Lamonte MJ, Church TS, Earnest CP, Fitzgerald SJ, Barlow CE, Jordan AN, Kampert JB, Blair SN,. 2004. Associations of muscle strength and fitness with metabolic syndrome in men. Med Sci Sports Exerc 36: 1301-1307.
23. Kim SK, Park SW, Hwang IJ, Lee YK, Cho YW,. 2010a. High fat stores in ectopic compartments in men with newly diagnosed type 2 diabetes: An anthropometric determinant of carotid atherosclerosis and insulin resistance. Int J Obes (Lond) 34: 105-110.
24. Kim TN, Choi KM,. 2013. Sarcopenia: Definition, epidemiology, and pathophysiology. J Bone Metab 20: 1-10.
25. Kim TN, Park MS, Kim YJ, Lee EJ, Kim MK, Kim JM, Ko KS, Rhee BD, Won JC,. 2014. Association of low muscle mass and combined low muscle mass and visceral obesity with low cardiorespiratory fitness. PLoS ONE 9: e100118.
26. Kim TN, Park MS, Lim KI, Choi HY, Yang SJ, Yoo HJ, Kang HJ, Song W, Choi H, Baik SH, Choi DS, Choi KM,. 2013a. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: The Korean Sarcopenic Obesity Study. Clin Endocrinol (Oxf) 78: 525-532.
27. Kim TN, Park MS, Lim KI, Yang SJ, Yoo HJ, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM,. 2011. Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Res Clin Pract 93: 285-291.
28. Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM,. 2010b. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 33: 1497-1499.
29. Kim TN, Won JC, Kim YJ, Lee EJ, Kim MK, Park MS, Lee SK, Kim JM, Ko KS, Rhee BD,. 2013b. Serum adipocyte fatty acid-binding protein levels are independently associated with sarcopenic obesity. Diabetes Res Clin Pract 101: 210-217.
30. Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM,. 2009. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: The Korean sarcopenic obesity study. Int J Obes (Lond) 33: 885-892.
31. Kohara K, Ochi M, Tabara Y, Nagai T, Igase M, Miki T,. 2011. Leptin in sarcopenic visceral obesity: Possible link between adipocytes and myocytes. PLoS ONE 6: e24633.
32. Kraegen EW, Cooney GJ,. 2008. Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol 19: 235-241.
33. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres JP,. 1993. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 58: 463-467.
34. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, Kim KW, Lim JY, Park KS, Jang HC,. 2010b. Sarcopenic obesity: Prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 33: 1652-1654.
35. Lim KI, Yang SJ, Kim TN, Yoo HJ, Kang HJ, Song W, Baik SH, Choi DS, Choi KM,. 2010a. The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: The Korean Sarcopenic Obesity Study (KSOS). Clin Endocrinol (Oxf) 73: 588-594.
36. Marques MD, Santos RD, Parga JR, Rocha-Filho JA, Quaglia LA, Miname MH, Avila LF,. 2010. Relation between visceral fat and coronary artery disease evaluated by multidetector computed tomography. Atherosclerosis 209: 481-486.
37. Martin SS, Qasim A, Reilly MP,. 2008. Leptin resistance: A possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 52: 1201-1210.
38. Marzetti E, Lees HA, Wohlgemuth SE, Leeuwenburgh C,. 2009. Sarcopenia of aging: Underlying cellular mechanisms and protection by calorie restriction. Biofactors 35: 28-35.
39. Morse WI, Soeldner JS,. 1964. The Non-Adipose Body Mass of Obese Women: Evidence of Increased Muscularity. Can Med Assoc J 90: 723-725.
40. O'Keefe JH, Bell DS,. 2007. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 100: 899-904.
41. Ochi M, Kohara K, Tabara Y, Kido T, Uetani E, Ochi N, Igase M, Miki T,. 2010. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 212: 327-332.
42. Pedersen BK, Febbraio MA,. 2012. Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol 8: 457-465.
43. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE,. 2008. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol 9: 629-635.
44. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M,. 2012. Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr 31: 583-601.
45. Rosen CJ, Bouxsein ML,. 2006. Mechanisms of disease: Is osteoporosis the obesity of bone. Nat Clin Pract Rheumatol 2: 35-43.
46. Sakuma K, Yamaguchi A,. 2013. Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol 2013: 204164.
47. Sasaki H, Kasagi F, Yamada M, Fujita S,. 2007. Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am J Med 120: 337-342.
48. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, Ferrucci L,. 2007. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 102: 919-925.
49. Stephen WC, Janssen I,. 2009. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 13: 460-466.
50. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC,. 2009. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15: 6973-6979.
51. Thornell LE,. 2011. Sarcopenic obesity: Satellite cells in the aging muscle. Curr Opin Clin Nutr Metab Care 14: 22-27.
52. Tilg H, Moschen AR,. 2006. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783.
53. Vettor R, Milan G, Franzin C, Sanna M, De Coppi P, Rizzuto R, Federspil G,. 2009. The origin of intermuscular adipose tissue and its pathophysiological implications. Am J Physiol Endocrinol Metab 297: E987-E998.
54. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ,. 2003. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52: 1355-1363.